Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• New technological advances propel the field of arrhythmia disorders Erik Swain
• The next decade of pediatric cardiology and cardiac surgery Thomas L. Spray, MD; Andrew N. Redington, MD
• Experts discuss FDA advisory against aspirin for primary prevention of MI, stroke
• FDA approves Entovis pacemaker for use during MRI
• FDA approves Epanova for severe hypertriglyceridemia
• FDA approves Zontivity to reduce MI, stroke in high-risk patients
• FDA denies PCI, bridge indications for cangrelor
• Metabolically healthy obesity is not without risk
• Brain, neck tumors reported in 3 dozen cath lab operators
• Calorie, fat intake increased over time among statin users
• Carotid artery stenosis classification, costs vary by institution
• CORONA: Statin therapy reduced risk for recurrent HF hospitalizations
• CTA provided accurate assessment of arterial plaque in patients with diabetes
• CTO PCI outcomes improving for patients with prior CABG
• Email, text, video show potential to improve chronic disease care
• Fewer adults eligible for hypertension treatment under 2014 BP guidelines
• First guideline issued on diagnosis, treatment of fetal cardiac disease
• Global burden of ischemic stroke on the rise
• Marijuana use may increase CV complications in young adults
• Peripheral vascular intervention found effective in women
• Physical activity can lower MI risk in older adults
• RIPCORD: Routine FFR measurement at coronary angiography influenced treatment plan
• Updated guideline advises BP control, lifestyle changes for stroke survivors
• INTREPID: Livalo safe, effective in patients with HIV at 1 year
• ALSYNC: Alternate site benefited patients with HF needing CRT
• Alternative access shows promise in extreme-risk patients treated with CoreValve
• Baseline characteristics predict recurrence after repair for severe ischemic MR
• CORP-2: Colchicine helped reduce recurrence of pericarditis
• ENGAGE-AF TIMI 48: Paroxysmal AF associated with lower stroke risk than other AF subtypes
• Fewer off-pump CABG procedures performed in past decade
• HARMONY: Ranolazine, dronedarone combination reduced AF burden
• Mesenchymal stromal stem cell injection improved heart function in patients with HF
• Mini-Cog test predicted 30-day outcomes for patients with HF
• Minimally invasive, robotic mitral valve surgery provide comparable clinical benefits
• PAINFREE SST: Longer ICD detection intervals safe for secondary prevention patients
• Paroxysmal AF ablation faster, more successful with cryoballoon
• PREDICt-RM: Remote monitoring reduced mortality in patients with ICDs, CRT-Ds
• Remote monitoring associated with greater survival for patients with pacemakers
• RESOLUTE: Low stent thrombosis rates reported with DAPT interruption
• Rise in postoperative BNP linked to higher mortality after transapical TAVR
• Risk index helped predict new-onset renal failure after heart transplant
• SIMPLE: Defibrillation testing safe, but did not improve outcomes
• VISTA: Substrate-based ablation improved outcomes in patients with VT
• Antithrombotic therapy in patients with AF undergoing PCI Michael B. Bottorff, PharmD, FCCP, FNLA, CLS; Brandon Cave, PharmD candidate; Sarah A. Spinler, PharmD, FCCP, FAHA, FASHP, AACC, BCPS (AQ Cardiology)
• ALSYNC
• FAST-MI
• MSC-HF
• PAINFREE SST
• SEATTLE II
• SIMPLE
• VISTA
• XIMA